Strongyloides stercoralis: Difference between revisions

No edit summary
 
(2 intermediate revisions by 2 users not shown)
Line 11: Line 11:


===Risk factors===
===Risk factors===
*Corticosteroid use, immunosuppression
*[[Corticosteroid]] use, immunosuppression
*Transplantation
*[[transplant complications|Transplantation]]
*Hematologic neoplasm
*Hematologic neoplasm (e.g. [[leukemia]])
*Human T-lymphotropic virus-1 infection (HTLV-1)
*Human T-lymphotropic virus-1 infection (HTLV-1)
*Malnutrition
*[[Malnutrition]]
*Diabetes
*[[Diabetes]]
*Chronic renal failure
*Chronic [[renal failure]]
*Chronic alcohol use
*Chronic [[alcohol Abuse|alcohol use]]


===Clinical significance===
===Clinical significance===
Line 29: Line 29:
===Dermatologic===
===Dermatologic===
*Larva currens: rapidly progressive pruritic linear eruption due to migration of larvae
*Larva currens: rapidly progressive pruritic linear eruption due to migration of larvae
*Perianal pruritis
*Perianal [[pruritus]]
*Foot pruritus (“ground itch”)
*Foot [[pruritus]] (“ground itch”)
 
===Respiratory===
===Respiratory===
*Dry cough
*Dry [[cough]]
*Wheezing
*[[Wheezing]]
*Loeffler’s-like syndrome: fever, shortness of breath, wheezing, pulmonary infiltrates
*Loeffler’s-like syndrome: [[fever]], [[shortness of breath]], [[wheezing]], pulmonary infiltrates


====Immunocompromised patients====
====Immunocompromised patients====
Line 48: Line 49:
*[[Atopic dermatitis]]
*[[Atopic dermatitis]]
*[[Asthma]]
*[[Asthma]]
*Allergic bronchopulmonary aspergillosis
*Allergic bronchopulmonary [[aspergillosis]]
*[[Coccidioidomycosis]]
*[[Coccidioidomycosis]]
*[[HIV]]
*[[HIV]]
*[[Churg-Strauss syndrome]]
*[[Churg-Strauss syndrome]]
*Eosinophilic leukemia]
*Eosinophilic [[leukemia]]


==Evaluation==
==Evaluation==
Line 69: Line 70:


===Immunosuppressed===
===Immunosuppressed===
*Combination therapy: albendazole 400mg BID x 7d AND ivermectin 200 mcg/kg daily x 1-2d<ref name="treat">Feely NM, Waghorn DJ, Dexter T, Gallen I, Chiodini.  Strongyloides stercoralis hyperinfection: difficulties in diagnosis and treatment.  Anaesthesia 2010; 65: 298-301.</ref>
*Combination therapy: [[albendazole]] 400mg BID x 7d AND [[ivermectin]] 200 mcg/kg daily x 1-2d<ref name="treat">Feely NM, Waghorn DJ, Dexter T, Gallen I, Chiodini.  Strongyloides stercoralis hyperinfection: difficulties in diagnosis and treatment.  Anaesthesia 2010; 65: 298-301.</ref>
*Antibiotics may need to be continued until there is evidence that parasite is cleared<ref name="treat" />
*Antibiotics may need to be continued until there is evidence that parasite is cleared<ref name="treat" />



Latest revision as of 04:15, 30 September 2019

Background

  • Intestinal nematode; roundworm
  • Endemic in tropical/subtropical areas such as Africa, Southeast Asia, Central/South America[1]

Life Cycle

  • Present in contaminated soil → larvae penetrate skin of hosts walking barefoot → enter venous circulation, migrate to lungs, then are expectorated to pharynx and swallowed → larvae develop into females that lay eggs asexually into GI tract, which hatch into larvae and are excreted into stool
  • Larvae either become sexually reproducing males/females or filariform larvae that can reinfect host
  • Autoinfection: Unique to Strongyloides; GI larvae can migrate from GI tract to venous system, then to lungs and proceed with life cycle
    • Can lead to dramatic increase in worm burden and hyperinfection in immunocompromised

Risk factors

Clinical significance

  • Chronic infection in immunosuppressed can lead to fulminant dissemination with case fatality rate as high as 70%; strong index of suspicion is needed in such cases

Clinical Features

Dermatologic

  • Larva currens: rapidly progressive pruritic linear eruption due to migration of larvae
  • Perianal pruritus
  • Foot pruritus (“ground itch”)

Respiratory

Immunocompromised patients

  • Respiratory and systemic symptoms such as fever will be more common[3]
  • Disseminated disease will invade multiple organ systems, including liver and brain

Differential Diagnosis

Evaluation

  • Establish possibility of infection (travel to endemic areas, etc)
  • Uncomplicated strongyloidiasis: 3 serial stool samples screened for ova and parasites, as well as ELISA for Strongyloides
    • Complicated strongyloidiasis: blood/sputum cultures, in addition to above
  • Notable eosinophilia in up to 70% of cases, though can be absent in immunosuppressed
  • Gram negative bacteremia may be present in immunocompromised

Management

Uncomplicated strongyloidiasis, normal immune system

  • Ivermectin 200 mcg/kg daily x 1-2d (drug of choice)

OR

  • Albendazole 400mg BID x 7d
  • Can consider albendazole prophylaxis in immigrants from endemic regions with consistent clinical presentation

Immunosuppressed

  • Combination therapy: albendazole 400mg BID x 7d AND ivermectin 200 mcg/kg daily x 1-2d[4]
  • Antibiotics may need to be continued until there is evidence that parasite is cleared[4]

Disposition

  • Discharge uncomplicated cases in those who are not immunosuppressed
  • Admit if immunocompromised or systemic symptoms

References

  1. Buonfrate D, Requena-Mendez A, Angheben A, Munoz J, Gobi F, Van Den Ende J, Bisoffi Z. Severe strongyloidiasis: a systematic review of case reports. BMC Infectious Diseases 2013, 13: 78. doi:10.1186/1471-2334-13-78
  2. Greaves D, Coggle S, Pollar C, Aliyu SH, Moore EM. Strongyloides stercoralis infection. BMJ 2013;347:f4610 doi: 10.1136/bmj.f4610 (Published 30 July 2013).
  3. Lim S, Katz K, Krajden S, Fuksa M, Keystone JS, Kain KC. Complicated and fatal Strongyloides infection in Canadians: risk factors, diagnosis and management. CMAJ 2004; 171 (5): 479-484.
  4. 4.0 4.1 Feely NM, Waghorn DJ, Dexter T, Gallen I, Chiodini. Strongyloides stercoralis hyperinfection: difficulties in diagnosis and treatment. Anaesthesia 2010; 65: 298-301.